{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:18:28Z","timestamp":1761581908092},"reference-count":69,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[1998,7,1]],"date-time":"1998-07-01T00:00:00Z","timestamp":899251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[1998,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Sera from vaccinees and controls who contracted serogroup B meningococcal disease during the blinded and open parts of a two-dose protection trial in Norway were compared for antigen-specific and bactericidal antibodies against vaccine strain 44\/76 (B:15:P1.7,16). From 16 of 20 (80%) vaccinees and 26 of 35 (74%) controls, one or more serum samples (\n            <jats:italic>n<\/jats:italic>\n            = 104) were collected during the acute phase (1 to 4 days), early convalescent phase (5 to 79 days), and late convalescent phase (8 to 31 months) after onset of disease. Binding of immunoglobulin G (IgG) to the major outer membrane antigens (80- and 70-kDa proteins, class 1, 3, and 5 proteins, and lipopolysaccharide [LPS]) on immunoblots was measured by digital image analysis. Specific IgG levels in vaccinees increased from acute to early convalescent phases, followed by a decline, while controls showed a small increase over time. Vaccinees had significantly higher levels than controls against class 1 and 3 porins and LPS in acute sera, against all antigens during early convalescence, and against class 1 and 3 porins in the later sera. Vaccinees who were infected with strains expressing subtype P1.7,16 proteins demonstrated a level of IgG binding to protein P1.7,16 with early-convalescent-phase sera that was fourfold higher than that of those infected with other strains. Bactericidal titers in serum against the vaccine strain were 192-fold higher for vaccinees than those for controls during early convalescence, but similarly low levels were found during late convalescence. A vaccine-induced anamnestic response of specific and functional antibody activities was thus shown, but the decrease in protection over time after vaccination indicated that two vaccine doses did not induce sufficient levels of long-term protective antibodies.\n          <\/jats:p>","DOI":"10.1128\/iai.66.7.3223-3231.1998","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T15:27:48Z","timestamp":1577806068000},"page":"3223-3231","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":79,"title":["Immune Responses against Major Outer Membrane Antigens of\n            <i>Neisseria meningitidis<\/i>\n            in Vaccinees and Controls Who Contracted Meningococcal Disease during the Norwegian Serogroup B Protection Trial"],"prefix":"10.1128","volume":"66","author":[{"given":"E.","family":"Wedege","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Vaccinology1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"H\u00f8iby","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Department of Bacteriology,2 National Institute of Public Health, N-0403 Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rosenqvist","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Vaccinology1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bjune","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Vaccinology1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00030-3"},{"key":"e_1_3_2_3_2","unstructured":"Andersen S. R. Personal communication."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.1995.0054"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.1997.0143"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.25.7.1155-1158.1987"},{"key":"e_1_3_2_7_2","unstructured":"Bjune\nG.\nH\u00f8iby\nE. A.\nDjupesland\nP.\nRosenqvist\nE.\nWedege\nE.\nAavitsland\nP.\nFr\u00f8holm\nL. O.\nOuter membrane vesicle vaccine against serogroup B meningococcal disease in Norway\nRecent advances in chemotherapy. Proceedings of the 18th International Congress of Chemotherapy Stockholm Sweden.\nEinhorn\nJ.\nNord\nC. E.\nNorrby\nS. R.\n1994\n750\n751\nAmerican Society for Microbiology\nWashington D.C"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91961-S"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)00037-N"},{"key":"e_1_3_2_10_2","first-page":"75","article-title":"Some agent characteristics and their coexistence related to the occurrence and severity of systemic meningococcal disease in Norway, winter 1981\u20131982.","volume":"6","author":"B\u00f8vre K.","year":"1983","unstructured":"B\u00f8vre K. Fr\u00f8holm L. O. Gaustad P. Holten E. H\u00f8iby E. A. Some agent characteristics and their coexistence related to the occurrence and severity of systemic meningococcal disease in Norway, winter 1981\u20131982. NIPH Ann. 6 1983 75 84","journal-title":"NIPH Ann."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.1994.1087"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0888-0786(87)90046-1"},{"key":"e_1_3_2_13_2","first-page":"86","article-title":"Antibody assisted protein refolding.","volume":"10","author":"Carlson J. D.","year":"1992","unstructured":"Carlson J. D. Yarmush M. L. Antibody assisted protein refolding. Bio\/Technology 10 1992 86 91","journal-title":"Bio\/Technology"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.13.4927"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549609049066"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.2.323-330.1994"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)34365-X"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(96)00020-5"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.1996.tb00067.x"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-142-9-2491"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)93086-3"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90340-9"},{"key":"e_1_3_2_23_2","first-page":"177","article-title":"Development and evaluation of group B serotype 2 protein vaccines: report of a group B field trial.","volume":"43","author":"Frasch C. E.","year":"1983","unstructured":"Frasch C. E. Coetzee G. Zahradnik J. M. Feldman H. A. Koornhof H. J. Development and evaluation of group B serotype 2 protein vaccines: report of a group B field trial. Med. Trop. (Marseille) 43 1983 177 180","journal-title":"Med. Trop. (Marseille)"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/7.4.504"},{"key":"e_1_3_2_25_2","unstructured":"Fredriksen\nJ. H.\nGriffiths\nE.\nGrotter\u00f8d\nE. M.\nH\u00f8iby\nE. A.\nRosenqvist\nE.\nStevenson\nP.\nWedege\nE.\nCharacterization of high molecular weight components in MenB-vaccine \u201cFolkehelsa \u201d an outer membrane vesicle vaccine against group B meningococcal disease\nPathobiology and immunobiology of Neisseriaceae.\nConde-Glez\nC. J.\nMorse\nS.\nRice\nP.\nSparling\nF.\nCalderon\nE.\n1994\n818\n824\nInstituto Nacional de Salud Publica\nCuernavaca Morelos Mexico"},{"key":"e_1_3_2_26_2","first-page":"67","article-title":"Production, characterization and control of MenB-vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease.","volume":"14","author":"Fredriksen J. H.","year":"1991","unstructured":"Fredriksen J. H. Rosenqvist E. Wedege E. Bryn K. Bjune G. Fr\u00f8holm L. O. Lindbak A. K. M\u00f8gster B. Namork E. Rye U. Stabbetorp G. Winsnes R. Aase A. Closs O. Production, characterization and control of MenB-vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann. 14 1991 67 80","journal-title":"NIPH Ann."},{"key":"e_1_3_2_27_2","first-page":"139","article-title":"Meningococcal strains isolated from teenage patients during the serogroup B vaccination trial in Norway: serotyping, serosubtyping, immunotyping and clonal analysis.","volume":"14","author":"Fr\u00f8holm L. O.","year":"1991","unstructured":"Fr\u00f8holm L. O. Caugant D. A. Holten E. H\u00f8iby E. A. Rosenqvist E. Wedege E. Meningococcal strains isolated from teenage patients during the serogroup B vaccination trial in Norway: serotyping, serosubtyping, immunotyping and clonal analysis. NIPH Ann. 14 1991 139 146","journal-title":"NIPH Ann."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1993.tb03320.x"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/150.1.71"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.11.4734-4742.1993"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.4.1437-1443.1994"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1993.tb03323.x"},{"key":"e_1_3_2_33_2","first-page":"147","article-title":"Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey.","volume":"14","author":"H\u00f8iby E. A.","year":"1991","unstructured":"H\u00f8iby E. A. Rosenqvist E. Fr\u00f8holm L. O. Bjune G. Feiring B. N\u00f8kleby H. R\u00f8nnild E. Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey. NIPH Ann. 14 1991 147 156","journal-title":"NIPH Ann."},{"key":"e_1_3_2_34_2","first-page":"107","article-title":"The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosis.","volume":"14","author":"H\u00f8iby E. A.","year":"1991","unstructured":"H\u00f8iby E. A. Bjune G. Fr\u00f8holm L. O. Eng J. Halstensen A. Rosenqvist E. R\u00f8nnild E. Wedege E. The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosis. NIPH Ann. 14 1991 107 123","journal-title":"NIPH Ann."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.9.2.186-188.1979"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-43-5-335"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-6215(83)84020-8"},{"key":"e_1_3_2_38_2","unstructured":"Jones\nD. M.\nBorrow\nR.\nFox\nA. J.\nCartwright\nK. A. V.\nRiordan\nT.\nHuman antibody response to the meningococcal class 1 protein\nPathobiology and immunology of Neisseriaceae.\nConde-Glez\nC. J.\nMorse\nS.\nRice\nP.\nSparling\nF.\nCalderon\nE.\n1994\n848\n852\nInstituto Nacional de Salud Publica\nCuernavaca Morelos Mexico"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/227680a0"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1989.tb00477.x"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.57.5.1590-1598.1989"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(84)90080-2"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.10.4419-4424.1994"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.12.5290-5295.1994"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.11.4510-4516.1992"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)85220-1"},{"key":"e_1_3_2_47_2","unstructured":"Peeters\nC. C. A. M.\nSchuller\nM.\nWestdijk\nJ.\nPoolman\nJ. T.\nSpecificity of bactericidal antibody responses in volunteers immunized with meningococcal B15P1.7 16 outer membrane proteins complexed to polysaccharide C and in patients infected with B15P1.7 16\nPathobiology and immunology of Neisseriaceae.\nConde-Glez\nC. J.\nMorse\nS.\nRice\nP.\nSparling\nF.\nCalderon\nE.\n1994\n880\n887\nInstituto Nacional de Salud Publica\nCuernavaca Morelos Mexico"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(96)00001-1"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1086\/514232"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.40.1.398-406.1983"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.26.8.1543-1548.1988"},{"key":"e_1_3_2_52_2","first-page":"5.2","article-title":"Meningococcal group B outer membrane vesicle vaccine trial among teen-agers in Norway.","volume":"1","author":"Rosenqvist E.","year":"1992","unstructured":"Rosenqvist E. H\u00f8iby E. A. Bjune B. Bryn K. Caugant D. A. Closs O. Fredriksen J. H. Gr\u00f8nnesby J. K. N\u00f8kleby H. Wedege E. Fr\u00f8holm L. O. Meningococcal group B outer membrane vesicle vaccine trial among teen-agers in Norway. Adv. Mod. Biotechnol. La Habana 1 1992 5.2","journal-title":"Adv. Mod. Biotechnol. La Habana"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.12.4642-4652.1995"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.1993.1070"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.5.1065"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.1997.tb01006.x"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.7.2745-2751.1996"},{"key":"e_1_3_2_58_2","first-page":"195","article-title":"Vaccines against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba.","volume":"14","author":"Sierra G. V. G.","year":"1991","unstructured":"Sierra G. V. G. Campa H. C. Varacel N. M. Garcia I. L. Izquierdo P. L. Sotolongo P. F. Casanueva G. V. Rico C. O. Rodriguez C. R. Terry M. H. Vaccines against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 14 1991 195 210","journal-title":"NIPH Ann."},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/149.3.387"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1995.1296"},{"key":"e_1_3_2_61_2","first-page":"183","article-title":"Immunoblotting studies of vaccinee and patient sera from a Norwegian serogroup B meningococcal vaccination trial.","volume":"14","author":"Wedege E.","year":"1991","unstructured":"Wedege E. Bjune G. Fr\u00f8holm L. O. H\u00f8iby E. A. Rosenqvist E. Immunoblotting studies of vaccinee and patient sera from a Norwegian serogroup B meningococcal vaccination trial. NIPH Ann. 14 1991 183 186","journal-title":"NIPH Ann."},{"key":"e_1_3_2_62_2","unstructured":"Wedege\nE.\nBolstad\nK.\nWetzler\nL. M.\nGuttormsen\nH. K.\nIgG antibody activity against meningococcal class 1 and 3 outer membrane proteins in patient sera: comparison between immunoblot and ELISA analyses\nAbstracts of the 10th International Pathogenic Neisseria Conference. Baltimore Md\nZollinger\nW. D.\nFrasch\nC. E.\nDeal\nC. D.\n1996\n190\n191"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(88)90381-X"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-38-1-23"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.51.2.571-578.1986"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-31-3-195"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.2.3.314-321.1995"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/126.5.514"},{"key":"e_1_3_2_69_2","unstructured":"Zollinger\nW. D.\nBoslego\nJ. W.\nMoran\nE. E.\nBrandt\nB. L.\nCruz\nC.\nMartinez\nM.\nGarcia\nJ.\nEffect of vaccination with meningococcal outer membrane protein vaccine on subsequent antibody reponses to carriage and natural infections\nPathobiology and immunobiology of Neisseriaceae.\nConde-Glez\nC. J.\nMorse\nS.\nRice\nP.\nSparling\nF.\nCalderon\nE.\n1994\n954\n960\nInstituto Nacional de Salud Publica\nCuernavaca Morelos Mexico"},{"key":"e_1_3_2_70_2","doi-asserted-by":"crossref","unstructured":"Zollinger W. D. and E. Moran. 1991. Meningococcal vaccines\u2014present and future. Trans. R. Soc. Trop. Med. Hyg. 85 (Suppl. 1) : 37\u201343.","DOI":"10.1016\/0035-9203(91)90339-Z"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.66.7.3223-3231.1998","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.66.7.3223-3231.1998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:25:45Z","timestamp":1646439945000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.66.7.3223-3231.1998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1998,7]]}},"alternative-id":["10.1128\/IAI.66.7.3223-3231.1998"],"URL":"https:\/\/doi.org\/10.1128\/iai.66.7.3223-3231.1998","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,7]]},"assertion":[{"value":"1997-09-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-04-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}